How does the combination of ibuprofen and paracetamol compare in efficacy to either agent alone for acute pain management?

Mechanism: Why Combine?

Paracetamol and ibuprofen act via distinct, complementary pathways: ibuprofen inhibits peripheral and central cyclo-oxygenase (COX) enzymes, reducing prostaglandin synthesis and inflammation, while paracetamol modulates central pain processing via serotonergic pathways with minimal peripheral anti-inflammatory effect. This mechanistic complementarity is the pharmacological rationale for additive or synergistic effects, validated by isobolographic analysis in preclinical models.

Efficacy Evidence

Postoperative and Dental Pain (Strongest Evidence)

Multiple RCTs and Cochrane-based systematic reviews consistently demonstrate combination superiority:

• An overview of Cochrane reviews found ibuprofen 200 mg alone achieves an NNT of 3.0, versus an NNT of 1.6 for ibuprofen 200 mg + paracetamol 500 mg, and 1.5 for ibuprofen 400 mg + paracetamol 1000 mg — a clinically meaningful improvement.
• A systematic review and critical analysis of RCTs in dental postoperative pain confirmed the combination provided greater pain relief than either ibuprofen or paracetamol alone, with AE rates similar to individual component drugs and sometimes lower than opioid-containing formulations.
• A factorial RCT of third-molar extraction found concurrent ibuprofen 400 mg + paracetamol 1000 mg delivered significantly better analgesia (SPRID8) than either agent alone across the 8-hour study window.
• A 2021 meta-analysis of the fixed-dose combination confirmed these findings with favourable safety data.

Dose-Sparing Effect

Lower combination doses can match higher monotherapy doses:

• Paracetamol 500 mg + ibuprofen 200–300 mg provides similar pain relief to ibuprofen 400 mg alone
• Paracetamol 500 mg + ibuprofen 250 mg significantly outperformed paracetamol 650 mg in pain relief, speed of onset, and duration (all P < 0.05)

Acute Musculoskeletal Pain (Emergency Department Setting)

Evidence here is more mixed and context-dependent:

• For acute non-traumatic, non-radicular low back pain, a well-conducted ED RCT found no significant difference between ibuprofen alone vs. ibuprofen + paracetamol at 1 week across pain and disability outcomes.
• A double-blind RCT of acute MSK pain in the ED found similar pain score reductions across paracetamol alone, ibuprofen alone, and the combination at 1 hour, with no significant between-group differences.
• An AHRQ systematic review noted that for acute musculoskeletal injury, an NSAID and paracetamol were "probably associated with similar effects" at multiple time points.

Safety

• Short-term combination use is generally well-tolerated, with AE rates comparable to monotherapy.
• In some studies, specific AEs (nausea, vomiting, headache, dizziness) were actually less frequent with the combination than with monotherapy at equivalent analgesic doses, likely reflecting the dose-sparing effect.
• The relative risk of any AE from ibuprofen 200 mg alone is 0.9 (95% CI 0.7–1.02), while for ibuprofen 200 mg + paracetamol 500 mg it is 0.7 (95% CI 0.6–0.9).
• Standard cautions apply: renal function monitoring with concurrent NSAIDs + paracetamol, and administration tracking to avoid paracetamol dose accumulation across products.

Guideline Positions

• The ASA and ERAS Society guidelines both recommend the paracetamol + NSAID combination as part of multimodal analgesia, emphasising opioid-sparing effects.
• The American Pain Society (APS)/ASRA/ASA unified guideline includes this combination as a core element of multimodal postoperative pain management.
• For mild-to-moderate acute pain, monotherapy with either agent is reasonable first-line; the combination is particularly indicated for moderate-to-severe pain or when monotherapy is insufficient.

Summary Table

Bottom line: The combination is best supported for moderate-to-severe postoperative and dental pain, where it consistently outperforms monotherapy with a favourable safety profile. For milder or musculoskeletal acute pain (especially low back pain), the incremental benefit over ibuprofen alone is less clear. Would you like me to drill into any specific pain type or patient population?